Skip to main content

GUIDED THERAPEUTICS INC (GTHP) Stock Forecast 2025 - AI Price Prediction & Analysis


GUIDED THERAPEUTICS INC (GTHP) AI Stock Price Forecast & Investment Analysis

GUIDED THERAPEUTICS INC Stock Price Chart and Technical Analysis

Loading GUIDED THERAPEUTICS INC interactive price chart and technical analysis...

GUIDED THERAPEUTICS INC (GTHP) - Comprehensive Stock Analysis & Investment Research

Deep dive into GUIDED THERAPEUTICS INC's business profile, financial performance, AI predictions, and competitive positioning to make informed investment decisions.

Understanding Company Overview

What this section covers: Essential business information about GUIDED THERAPEUTICS INC, including sector classification, industry positioning, and organizational structure.

How to interpret: Company size, sector, and employee count provide context for market position and growth potential. Leadership and founding date indicate stability and experience.

For GUIDED THERAPEUTICS INC: GUIDED THERAPEUTICS INC operates in the Industrial Applications and Services sector, making it an emerging small-cap investment.

GUIDED THERAPEUTICS INC (Stock Symbol: GTHP) is a leading company in the Industrial Applications and Services sector , specifically operating within the Electromedical & Electrotherapeutic Apparatus industry.

.

The company has established itself as an emerging investment opportunity with substantial growth potential.

Understanding Financial Performance

What these metrics mean: Key financial indicators showing GUIDED THERAPEUTICS INC's revenue scale, profitability, market value, and shareholder returns.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For GUIDED THERAPEUTICS INC:

Market Capitalization: $18 million - Classified as a small-cap investment offering high growth potential.

Understanding AI Stock Predictions

What these predictions mean: AI-powered forecasts for GUIDED THERAPEUTICS INC stock using machine learning algorithms trained on historical market data and technical indicators.

How to interpret: Positive percentages indicate expected price increases, negative values suggest potential declines. Accuracy scores show historical prediction reliability.

For GUIDED THERAPEUTICS INC: Unlock premium access to view detailed AI predictions and price targets.

🚀 Unlock Premium AI Predictions to access our advanced machine learning forecasts for GUIDED THERAPEUTICS INC stock, including 7-day, 30-day, and 90-day price targets with confidence intervals and risk assessments.

Understanding Market Position

What this analysis covers: GUIDED THERAPEUTICS INC's competitive positioning, market dynamics, operational efficiency, and strategic advantages within its industry.

How to evaluate: Strong cash flow generation, healthy margins, and market leadership indicate competitive advantages. Growth rates show expansion potential.

For GUIDED THERAPEUTICS INC: Market positioning analysis based on available financial and operational metrics.

GUIDED THERAPEUTICS INC strategically competes in the highly dynamic Electromedical & Electrotherapeutic Apparatus marketplace, representing an emerging small-cap investment with substantial growth potential and market disruption capabilities .

GUIDED THERAPEUTICS INC (GTHP) Fundamental Analysis & Insider Trading Data (Quarterly Financial Reports)

Comprehensive quarterly financial data, earnings trends, insider transactions, and institutional holdings for GUIDED THERAPEUTICS INC stock analysis.

Loading GUIDED THERAPEUTICS INC comprehensive fundamental analysis and insider trading data...

Deep dive into GUIDED THERAPEUTICS INC's financial health, valuation metrics, and operational efficiency to make informed investment decisions.

Understanding Valuation Metrics

What these metrics mean: Valuation metrics help determine if GUIDED THERAPEUTICS INC stock is fairly priced compared to its earnings, assets, and market position.

How to read them: Lower P/E ratios may indicate undervalued stocks, while higher ratios suggest growth expectations. P/B ratio compares market value to book value.

For GUIDED THERAPEUTICS INC:

Market Cap $18M
EPS $-0.05
Understanding Profitability Metrics

What these metrics mean: These ratios measure how efficiently GUIDED THERAPEUTICS INC converts revenue into profit and generates returns for shareholders.

How to read them: Higher ROE/ROA indicate better management efficiency. Margin percentages show profit at different operational levels.

For GUIDED THERAPEUTICS INC:

Understanding Financial Health Metrics

What these metrics mean: These ratios assess GUIDED THERAPEUTICS INC's ability to meet short-term obligations and manage debt levels effectively.

How to read them: Current ratio >2 is generally good, Quick ratio >1 shows strong liquidity. Lower D/E ratios indicate conservative debt management.

For GUIDED THERAPEUTICS INC:

Understanding Cash Flow Metrics

What these metrics mean: Cash flow metrics reveal GUIDED THERAPEUTICS INC's ability to generate cash from operations and fund growth initiatives.

How to read them: Positive operating cash flow is crucial. Free cash flow shows money available for dividends, buybacks, or investments.

For GUIDED THERAPEUTICS INC:

Understanding Operational Efficiency Metrics

What these metrics mean: These ratios measure how effectively GUIDED THERAPEUTICS INC uses its assets and manages working capital.

How to read them: Higher turnover ratios indicate efficient asset utilization. Shorter collection periods show effective credit management.

For GUIDED THERAPEUTICS INC:

Understanding Financial Statement Data

What these metrics mean: Key figures from GUIDED THERAPEUTICS INC's income statement and balance sheet showing absolute financial performance.

How to read them: Revenue shows business scale, while margins indicate profitability. Balance sheet items reveal financial structure.

For GUIDED THERAPEUTICS INC:

Income Statement ($ Millions)
Balance Sheet Highlights (% Of Assets)
Dividend & Shareholder Information
Shares Outstanding 79M

Latest GUIDED THERAPEUTICS INC Stock News & Market Analysis

Breaking news, analyst reports, and market updates affecting GUIDED THERAPEUTICS INC (GTHP) stock price and investment outlook.

GUIDED THERAPEUTICS INC Competitors & Peer Analysis - Industrial Applications and Services Sector

Comparative analysis of GUIDED THERAPEUTICS INC against industry peers and competitors in the Industrial Applications and Services sector, featuring AI-powered forecasts and key financial metrics.

Company Ticker Symbol 90-Day AI Forecast Market Cap (USD M) P/E Ratio P/B Ratio
AXGN Unlock Forecast - 30 Days FREE Trial $759M -41.7x 6.8x
CBLL Unlock Forecast - 30 Days FREE Trial $465M x 2.7x
CNMD Unlock Forecast - 30 Days FREE Trial $1398M 12.7x 1.4x
CV Unlock Forecast - 30 Days FREE Trial $12M x x
ECOR Unlock Forecast - 30 Days FREE Trial $37M -7.3x 32.9x
EDAP Unlock Forecast - 30 Days FREE Trial $84M x 2.1x
ELMD Unlock Forecast - 30 Days FREE Trial $203M 26.9x 4.7x
FONR Unlock Forecast - 30 Days FREE Trial $103M 9.9x 0.7x
GTHP Unlock Forecast - 30 Days FREE Trial $18M x x
INMD Unlock Forecast - 30 Days FREE Trial $1055M x 1.5x
IRIX Unlock Forecast - 30 Days FREE Trial $17M -2.8x 2.9x
IRME Unlock Forecast - 30 Days FREE Trial $2M x x
ITGR Unlock Forecast - 30 Days FREE Trial $3613M 43.7x 2.1x
LIVN Unlock Forecast - 30 Days FREE Trial $2938M -662.0x 2.6x
MASI Unlock Forecast - 30 Days FREE Trial $7994M 128.1x 7.7x
MDT Unlock Forecast - 30 Days FREE Trial $122777M 26.4x 2.6x
NRXS Unlock Forecast - 30 Days FREE Trial $30M -0.9x 7.0x
NXL Unlock Forecast - 30 Days FREE Trial $26M -4.7x 4.4x
OM Unlock Forecast - 30 Days FREE Trial $235M -0.4x 1.5x
SMLR Unlock Forecast - 30 Days FREE Trial $317M 8.6x 0.8x
STRR Unlock Forecast - 30 Days FREE Trial $35M -1.6x 0.6x
STRRP Unlock Forecast - 30 Days FREE Trial $31M -5.5x 0.5x
STXS Unlock Forecast - 30 Days FREE Trial $263M -8.4x 180.4x
TIVC Unlock Forecast - 30 Days FREE Trial $3M 0.0x 0.8x
TMDX Unlock Forecast - 30 Days FREE Trial $3911M 54.6x 12.3x
VASO Unlock Forecast - 30 Days FREE Trial $21M 20.1x 0.8x
ZYXI Unlock Forecast - 30 Days FREE Trial $40M 41.4x 32.0x

Frequently Asked Questions - GUIDED THERAPEUTICS INC Stock Forecast

How accurate are GUIDED THERAPEUTICS INC stock predictions?

Our AI model demonstrates 66% historical accuracy for GTHP predictions, based on advanced machine learning algorithms trained on over 10 years of market data.

What factors influence GUIDED THERAPEUTICS INC stock price forecasts?

Our analysis considers GUIDED THERAPEUTICS INC's financial metrics, Industrial Applications and Services sector trends, market sentiment, technical indicators, earnings data, and macroeconomic factors affecting stock performance.

Is GUIDED THERAPEUTICS INC a good investment in 2025?

Based on our AI analysis, GUIDED THERAPEUTICS INC shows potential for various market scenarios. Consider your risk tolerance, investment timeline, and portfolio diversification before making investment decisions.

How often are GUIDED THERAPEUTICS INC forecasts updated?

GUIDED THERAPEUTICS INC stock forecasts are updated daily using real-time market data, ensuring you receive the most current AI-powered predictions and investment insights.

Want More Advanced GUIDED THERAPEUTICS INC Analysis?

Unlock premium features including detailed price targets, risk assessments, portfolio optimization, and real-time alerts for GUIDED THERAPEUTICS INC stock.

My Portfolio

Investment Dashboard

Loading your portfolio...